High sensitive cardiac troponin T: Testing the test.

Area of Science:

• Cardiology
• Biomarkers
• Diagnostic Accuracy

Background:

• High-sensitive cardiac troponin T (hs-TnT) is widely used for acute myocardial infarction (AMI) diagnosis.
• hs-TnT levels vary significantly based on patient pathophysiology.
• The diagnostic applicability of the current hs-TnT assay requires further investigation.

Purpose of the Study:

• To evaluate the diagnostic performance of the current hs-TnT assay for acute myocardial infarction (AMI).
• To assess the specificity and sensitivity of hs-TnT in a diverse patient population.

Main Methods:

• Retrospective analysis of 1573 patients' hs-TnT results from an emergency department.
• Categorization of patients into acute cardiac events (NSTEMI, STEMI) and control groups.
• Receiver Operating Characteristic (ROC) curve analysis to determine diagnostic accuracy.

Main Results:

• Overall hs-TnT sensitivity for acute cardiac events exceeded 92%.
• Specificity varied around 35%, indicating limited discriminatory power.
• Area Under the Curve (AUC) for total cardiac events was 0.81, with AUCs of 0.79 for NSTEMI and 0.84 for STEMI.
• The ESC algorithm showed 83% sensitivity for NSTEMI but misclassified 43% of non-NSTEMIs.

Conclusions:

• The hs-TnT assay exhibits very low specificity for diagnosing AMI.
• Current hs-TnT assays, including delta values, reflect general myocardial damage rather than specific AMI.
• Myocardial damage alone, as indicated by hs-TnT, is insufficient for AMI diagnosis, even with established algorithms.